The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Veeva Systems Inc. (NYSE:VEEV) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.

On June 23, Veeva Systems Inc. (NYSE:VEEV) announced that it acquired Copli and launched Veeva Falcon MLR. It made the agentic medical, legal, and regulatory content-review platform available immediately.

The firm said Veeva Falcon MLR automates reviews of promotional and medical content by checking materials against approved labels and local regulations. The corporation noted that the platform has the potential to eliminate more than 70% of manual MLR work over the next five years.

Copli CEO Jacob Scheel-Bech called the launch "a fundamental shift" in content review. He said the acquisition will help scale the company's vision for AI-focused MLR while merging its technology with Veeva PromoMats.

Emma Hyland, vice president of Veeva Commercial Content, said the MLR process has long slowed the delivery of information to patients and physicians. She commented that Veeva Falcon MLR can shorten review cycles by automating routine work, allowing reviewers to focus on higher-value responsibilities.

Veeva Systems Inc. (NYSE:VEEV) provides cloud-based software for the life sciences market in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.

While we acknowledge the potential of VEEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.

Disclosure: None. Follow Insider Monkey on Google News.